Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Transpact Enterprises Ltd
Your Vote -
Buy
33.33%
Hold
0.00%
Sell
66.67%
33.33%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Transpact Enterprises Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Transpact Enterprise - Board Meeting Outcome for Appointment Of Ms. Priya Goel As Additional (Non Executive Independent) Dire
-
Transpact Enterprise has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Transpact Enterprise - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Transpact Enterprises Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 0.4964 | 0.8118 | 0.8928 | 1.1136 | 1.1448 |
| Liabilities | 0.4964 | 0.8118 | 0.8928 | 1.1136 | 1.1448 |
| Equity | 0.3867 | 0.3867 | 0.3867 | 0.3867 | 0.3867 |
| Gross Profit | -0.0579 | -0.03 | -0.2078 | -0.0489 | -0.4106 |
| Net Profit | -0.0909 | -0.0659 | -0.2209 | -0.0641 | -0.4333 |
| Cash From Operating Activities | 0.3928 | 0.0085 | -0.0322 | 0.0111 | -1.1412 |
| NPM(%) | 0 | -17.22 | -147.26 | -256.69 | 0 |
| Revenue | 0 | 0.3825 | 0.15 | 0.025 | 0 |
| Expenses | 0.0579 | 0.4125 | 0.3578 | 0.0739 | 0.4106 |
| ROE(%) | -20.54 | -14.89 | -49.91 | -14.5 | -97.93 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Transpact Enterprises Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 810.05 | -1.12 | 26.88 | 122.70 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 74.39 | 0.39 | 308.58 | 447.12 | 14.01 | 0.68 |
| Bharat Immunological and Biologicals Corporation Ltd | 25.66 | -5.45 | 0.00 | 928.37 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 698.00 | -1.87 | 0.00 | 421.60 | -687.11 | 0.00 |
Company Info
The Company was incorporated as "Transpact Enterprises Private Limited" on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai at Maharashtra bearing Registration No. 243247. Further, the status of the Company was changed to a public limited company and the name of the Company was changed to "Transpact Enterprises Limited" by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019 by the Registrar of Companies, Mumbai. The Company's Corporate Identity Number is U33130MH2013PLC243247MAJOR EVENTS IN THE HISTORY OF THE COMPANY :2013- Incorporated as "Transpact Enterprises Private Limited"2015- Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator- Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.2016- Received ISO 9001:2015 certification for quality management system- Received 13485:2016 certification for "Medical devices"2018- Assessed and registered as compliance as per the requirements of Council Directive- MEDICAL DEVICES DIRECTIVE - 2007/47/EC by International Standards Registrations.2019- Conversion of Private Company "Transpact Enterprises Private Limited" to Public Company "Transpact Enterprises Limited".
The Company was incorporated as "Transpact Enterprises Private Limited" on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai at Maharashtra bearing Registration No. 243247. Further, the status of the Company was changed to a public limited company and the name of the Company was changed to "Transpact Enterprises Limited" by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019 by the Registrar of Companies, Mumbai. The Company's Corporate Identity Number is U33130MH2013PLC243247MAJOR EVENTS IN THE HISTORY OF THE COMPANY :2013- Incorporated as "Transpact Enterprises Private Limited"2015- Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator- Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.2016- Received ISO 9001:2015 certification for quality management system- Received 13485:2016 certification for "Medical devices"2018- Assessed and registered as compliance as per the requirements of Council Directive- MEDICAL DEVICES DIRECTIVE - 2007/47/EC by International Standards Registrations.2019- Conversion of Private Company "Transpact Enterprises Private Limited" to Public Company "Transpact Enterprises Limited".
Read More
Parent Organisation
Transpact Enterprises Ltd.
Founded
12/05/2013
Managing Director
NSE Symbol
FAQ
The current price of Transpact Enterprises Ltd is
The 52-week high for Transpact Enterprises Ltd is
The market capitalization of Transpact Enterprises Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Transpact Enterprises Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Transpact Enterprises Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Transpact Enterprises Ltd shares.
The CEO of Transpact Enterprises Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
